ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding ESSA Pharma Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 36 | 36 | 0 |
| Shares | 31.7M | 31.0M | −710.6K (−2.2%) |
| Value | $50.1M | $52.7M | +$2.59M (+5.2%) |
New holders (4)
Institutions that held ESSA Pharma Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LMR Partners LLP | 200,000 | $340.0K | 0.01% |
| Rangeley Capital, LLC | 170,000 | $289.0K | 0.36% |
| ADAR1 Capital Management, LLC | 50,000 | $85.0K | 0.01% |
| Jane Street Group, LLC | 43,907 | $74.6K | 0.00% |
Sold out (4)
Institutions that held ESSA Pharma Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Altium Capital Management LP | 1,050,369 | $1.66M |
| Deuterium Capital Management, LLC | 110,412 | $174.5K |
| Cubist Systematic Strategies, LLC | 14,115 | $22.3K |
| Laurel Wealth Advisors LLC | 600 | $948 |